CAS 76824-35-6
:Famotidina
- 3-[(2-Diaminomethyleneaminothiazol-4-yl)methylthio]-N-sulfamoylpropionamidine
- 3-[([2-[(Diaminomethylidene)amino]-1,3-thiazol-4-yl]methyl)sulfanyl]-N-sulfamoylpropanimidamide
- 3-[({2-[(Hydrazonomethyl)amino]thiazol-4-yl}methyl)thio]-N-sulfamoylpropionamidine
- 3-[[2-(Diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N′-sulfamoylpropanimidamide
- 3-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]-N-(aminosulfonyl)propanimidamide
- Agufam
- Amfamox
- Antodine
- Apo-Famotidine
- Apogastine
- Bestidine
- Brolin
- Cepal
- Digervin
- Dispromil
- Dispronil
- Durater
- Facid
- Fadin
- Fadine
- Fadyn
- Fagastine
- Famo
- FamoABZ
- Famocid
- Famodar
- Famodil
- Famodin
- Famodine
- Famogard
- Famogast
- Famolta
- Famonerton
- Famopsin
- Famos
- Famosan
- Famoser
- Famostagine-D
- Famotal
- Famotep
- Famotin
- Famotine
- Famowal
- Famox
- Famoxal
- Fanosin
- Fanox
- Farmotex
- Fenox
- Fibonel
- Fudone
- Fuweidin
- Ganor
- Gaster
- Gastridin
- Gastrion
- Gastro
- Gastrodomina
- Gastropen
- Ifada
- Kemofam
- Lecedil
- Logos
- Mosul
- Motiax
- Muclox
- N-(Aminosulfonyl)-3-[[[2-[(diaminomethylene)amino]-4-thiazolyl]methyl]thio]propanimidamide
- Nevofam
- Nulcerin
- Panalba
- Pepcid
- Pepcidin
- Pepcidina
- Pepcidine
- Pepdif
- Pepdine
- Pepdul
- Pepfamin
- Peptan
- Peptec
- Peptifam
- Pepzan
- Purifam
- Quamatel
- Quamtel
- Restadin
- Rogasti
- Servipep
- Supertidine
- Tamin
- Topcid
- Ulcatif
- Ulcedine
- Ulceran
- Ulcetrax
- Ulcidine
- Ulcofam
- Ulfagel
- Ulfam
- Ulfamid
- Ulfinol
- Ulped
- Weimok
- [Amino-3-[[[2-[(Diaminomethylene)Amino]-4-Thiazolyl]-Methyl]Thio]Propylidene]
- Propanimidamide, 3-[[[2-[(aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]-N-(aminosulfonyl)-
- Famotidine
- Famotidine (Patented-No Supply)
- Ver mais sinónimos
Famotidine
CAS:Fórmula:C8H15N7O2S3Pureza:>98.0%(T)(HPLC)Cor e Forma:White to Almost white powder to crystalPeso molecular:337.44Famotidine, 98+%
CAS:A competitive histamine H2 receptor antagonist
Fórmula:C8H15N7O2S3Pureza:98+%Peso molecular:337.45Famotidine
CAS:FamotidineFórmula:C8H15N7O2S3Pureza:99.7%Cor e Forma:White. To. Off-WhitePeso molecular:337.04494FAMOTIDINE FOR SYSTEM SUITABILITY CRS
CAS:FAMOTIDINE FOR SYSTEM SUITABILITY CRSFórmula:C8H15N7O2S3Peso molecular:337.4454Famotidine
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFórmula:C8H15N7O2S3Cor e Forma:PowderPeso molecular:337.45Famotidine
CAS:Famotidine, a histamine H2-blocker, curbs gastric acid production, lowering volume and acidity.Fórmula:C8H15N7O2S3Pureza:98.93% - 99.91%Cor e Forma:White To Off-White Crystalline PowderPeso molecular:337.453-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N-sulfamoylpropanimidamide
CAS:Fórmula:C8H15N7O2S3Pureza:97%Cor e Forma:SolidPeso molecular:337.4454Ref: IN-DA003QKN
1g24,00€5g52,00€15g106,00€1kgA consultar25g129,00€2kgA consultar100g297,00€500gA consultarFamotidine
CAS:Fórmula:C8H15N7O2S3Pureza:≥ 98.0%Cor e Forma:White to off-white powderPeso molecular:337.45Famotidine-d4 (Major)
CAS:Produto ControladoApplications Famotidine-d4 is the labeled analogue of Famotidine (F102250), a histamine H2-receptor antagonist. Antiulcerative.
References Takeda, M., et al.: Arzneim.-Forsch., 32, 734 (1982); Miwa, M., et al.: J. Clin. Pharmacol. Ther. Toxicol., 22, 214 (1984); Takabatke, T., et al.: Eur. J. Clin. Pharmacol., 28, 327 (1985)Fórmula:C8H11D4N7O2S3Cor e Forma:NeatPeso molecular:341.47Famotidine
CAS:Produto ControladoApplications Histamine H2-receptor antagonist. Antiulcerative.
References Takeda, M., et al.: Arzneim.-Forsch., 32, 734 (1982), Miwa, M., et al.: J. Clin. Pharmacol. Ther. Toxicol., 22, 214 (1984), Takabatke, T., et al.: Eur. J. Clin. Pharmacol., 28, 327 (1985),Fórmula:C8H15N7O2S3Cor e Forma:White To Off-WhitePeso molecular:337.45Famotidine
CAS:Famotidine is a selective histamine H2-receptor antagonist used in the treatment of gastric hypersecretory disorders. Famotidine is effective in the treatment of duodenal and gastric ulcers, particularly when they are caused by the prolonged use of nonsteroidal antiinflammatory drugs (NSAIDs). To improve retention in the stomach, famotidine has experimentally been formulated as buoyant tablets that remained floating for up to 10 hours in vitro (Jaimini, 2007).
Fórmula:C8H15N7O2S3Pureza:Min. 98 Area-%Cor e Forma:White PowderPeso molecular:337.45 g/mol3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N-sulfamoylpropanimidamide
CAS:Fórmula:C8H15N7O2S3Pureza:97%Peso molecular:337.44















